Aclaris Therapeutics
ACRS
#7955
Rank
A$0.35 B
Marketcap
$4.95
Share price
-5.52%
Change (1 day)
253.12%
Change (1 year)

Aclaris Therapeutics (ACRS) Fails to deliver data

Key failure to deliver metrics for Aclaris Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Aclaris Therapeutics (ACRS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Aclaris Therapeutics (ACRS) - since 2015

Volume in USD (price x number of shares), data since 2015

Aclaris Therapeutics (ACRS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$0.43 M-90.16%
2023A$4.44 M138.96%
2022A$1.86 M-98.82%
2021A$0.15 B5540.04%
2020A$2.8 M-10.83%
2019A$3.14 M-24.41%
2018A$4.15 M-88.34%
2017A$35.66 M1625.66%
2016A$2.06 M-84.63%
2015A$13.44 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$1 MA$6 M๐Ÿ‡บ๐Ÿ‡ธ USA